Array Bio stops study testing drug for ovarian cancer

(Reuters) - Array BioPharma Inc said it was abandoning a late-stage study testing its experimental drug on ovarian cancer patients, after an interim analysis showed the trial would likely fail.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro